Enact Holdings, Inc.
In the published model solve dated 2026-Q2, anchored at $49.07, Enact Holdings, Inc. (ACT) is priced for 9.9% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Enact insures the top slice of a mortgage rather than the whole loan, and the filing sizes that slice precisely: ⟦"our risk across all policies written is approximately 25% of the underlying primary insurance in-force"⟧, so a foreclosure costs the insurer a fraction of the loan balance. • The structural risk is the accounting rather than the underwriting, because reserves attach only to ⟦"loans that servicers have reported to us as being in default, which is typically after the second missed p
Is ACT overvalued? See what's priced in →
243 institutional managers reported holding ACT in 13F filings for the quarter ended 2026-03-31. Together they hold about 19% of the company; the top 10 hold 11%. 34 opened new positions that quarter. Held by BlackRock, Dimensional Fund Advisors, State Street, among others. On the short side, 3.8M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (12.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
ACT has cut its share count 13% over the past five years, spending $808.86M on repurchases. It pays a dividend, and has paid one every year in our records (6 and counting); the current rate is $0.81 a share annually. Cash returned over the past three years: $426.82M in dividends and $743.89M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at ACT over the trailing three years: 2024: 1 buy totaling $270k. 7 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ACT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-03-01 | -8.3% | -2.6% |
| 2023-05-06 | -7.7% | +6.9% |
| 2023-08-05 | +3.6% | -3.5% |
| 2023-11-03 | +1.2% | +0.7% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ACT's latest 8-K filings: 2026-08-05 (items 2.02, 9.01); 2026-05-15 (items 5.07); 2026-05-05 (items 2.02, 9.01); 2026-02-03 (items 2.02, 8.01, 9.01); 2025-11-05 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.